Cargando…
MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.
Alteration in MHC class I expression may be used by cancer cells to avoid immune destruction. Much experimental evidence supports this idea, although survival studies are very scarce. To investigate whether the presence or absence of HLA-A, -B and -C antigens in laryngeal carcinoma influences surviv...
Autores principales: | Esteban, F., Redondo, M., Delgado, M., Garrido, F., Ruiz-Cabello, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077227/ https://www.ncbi.nlm.nih.gov/pubmed/8956796 |
Ejemplares similares
-
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
por: Esteban, F., et al.
Publicado: (1990) -
Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
por: Ferguson, A., et al.
Publicado: (1985) -
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
por: López-Nevot, M. A., et al.
Publicado: (1989) -
Role of infiltrated leucocytes in tumour growth and spread
por: Lin, E Y, et al.
Publicado: (2004) -
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
por: Walter, W, et al.
Publicado: (2000)